Quantitative Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Quantitative Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-37,863	Closed	-$110K	–	657
2020 Q2	$110K	Buy	+37,863	New	+$120K	0.01%	484
2019 Q1	–	Sell	-23,100	Closed	-$66K	–	916
2018 Q4	$66K	Buy	+23,100	New	+$63.5K	﹤0.01%	530
2016 Q3	–	Sell	-35,200	Closed	-$110K	–	994
2016 Q2	$110K	Sell	35,200 -67,000	-66%	-$223K	0.01%	701
2016 Q1	$340K	Buy	102,200 +58,200	+132%	+$181K	0.02%	611
2015 Q4	$155K	Buy	+44,000	New	+$184K	0.01%	652
2015 Q2	–	Sell	-10,400	Closed	-$73K	–	827
2015 Q1	$73K	Buy	+10,400	New	+$75.3K	0.01%	591
2014 Q3	–	Sell	-12,100	Closed	-$117K	–	623
2014 Q2	$117K	Buy	+12,100	New	+$108K	0.02%	428
2013 Q3	–	Sell	-11,200	Closed	-$86K	–	740
2013 Q2	$86K	Buy	+11,200	New	+$87.3K	0.02%	428

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Quantitative Investment Management's PDLI Position: Q3 2020 in Review

Quantitative Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 37,863 shares — an estimated $110K sold.

Quantitative Investment Management first reported a position in PDLI in Q2 2013 and held it in 8 quarters. The position peaked at $340K in Q1 2016. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

Quantitative Investment Management reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
Quantitative Investment Management sold 37,863 PDL BioPharma, Inc. shares in Q3 2020, an estimated $110K.
Quantitative Investment Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 8 quarters.
Quantitative Investment Management's PDL BioPharma, Inc. position peaked at $340K in Q1 2016.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Quantitative Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.